West Pharmaceutical Services Inc: director Janet Haugen received 44 shares

What happened The filing says Janet Brutschea Haugen, a director, received 44 shares as a derivative award (transaction code A) on Sep 30, 2026 at $370.76 per share, totaling $16,313. The award is reported as a derivative (phantom stock/RSU-type) grant.

Key details

• Transaction date and price: Sep 30, 2026; $370.76 per share; total value $16,313.
• Shares owned after the transaction: not specified in the filing.
• Relevant footnotes from the filing:
  • F1: Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
  • F2: Awards of phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
• Filing date: Oct 2, 2026 (the filing does not indicate a late filing status).

Why it may matter

• This was a derivative award/grant rather than a market purchase or sale; the units are to be settled or vested per the plan terms.
  This filing does not show why the insider traded or why the company acted.